Stock AnalizCrocs, Inc. CROX
Shoe Manufacturing · IPO 2006 · data as of November 13, 2026
Crocs, Inc. (CROX) is a consumer discretionary company listed in the US with a market value of about $7.5B. In the twelve months to September 30, 2026 it had revenue of $4.1B and net income of $664M, a net margin of 16.2%.
Its overall Stock Analiz score is 2.2 out of 5 (weak). The strongest part is value (4/5); the weakest is future growth (0/5).
Key numbers: a P/E of 12.4, a price to free cash flow of 9.9, 5-year revenue growth of 24% a year, a 5-year average ROIC of 25%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 63% above the current price.
Score: 2.2 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
- Positive free cash flow
- Debt below 3 years of free cash flow
Checks not passed
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- Profitable 5 years in a row
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.1B | $4.0B | $4.1B | $4.0B | $3.6B | $2.3B | $1.4B | $1.2B | $1.1B | $1.0B | $1.0B |
| Net income | $664M | -$81M | $950M | $793M | $540M | $726M | $313M | $119M | $50M | $10M | -$16M |
| Free cash flow | $754M | $659M | $923M | $815M | $499M | $511M | $225M | $53M | $102M | $85M | $18M |
| EPS (diluted) | $13.24 | $-1.50 | $15.88 | $12.79 | $8.71 | $11.39 | $4.56 | $1.66 | $-1.01 | $-0.07 | $-0.43 |
| Net margin | 16.2% | -2.0% | 23.2% | 20.0% | 15.2% | 31.4% | 22.6% | 9.7% | 4.6% | 1.0% | -1.6% |
| ROIC | — | 4.0% | 22.6% | 26.8% | 18.5% | 54.4% | 25.5% | 19.3% | 18.0% | 5.2% | -2.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 12 analysts is $164.67, 1% above the current price; targets range from $128.00 to $190.00; the consensus rating is “Buy”; expected EPS is $14.63 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Crocs’s P/E ratio?
About 12.4, based on the last twelve months of diluted earnings per share (forward P/E about 11.0).
Is Crocs stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 63% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Crocs pay a dividend?
Not currently.
Is Crocs a good stock to buy?
We do not give buy or sell advice. Crocs scores 2.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.